Pharmaking Ranitidine Tablet (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Pharmaking Co., Ltd.
MFDS item code 199601963 · Notified 1996.09.07
This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treats acid-related disorders (such as ulcers), improves gastric mucosal lesions, and prevents Mendelson syndrome
This medication is effective for various gastric disorders such as ulcers occurring in the stomach and duodenum, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used to prevent Mendelson's syndrome during pre-anesthesia and to treat ulcers post-surgery. It helps with gastric and duodenal ulcers resulting from NSAID administration, acute exacerbations of both acute and chronic gastritis, and improves gastric mucosal lesions accompanied by upper gastrointestinal bleeding. It can also be used to relieve symptoms associated with excessive gastric acid, heartburn, and acid regurgitation. Overall, this medication is used to improve and treat symptoms associated with various gastric disorders.
Adults Administer 150 mg of ranitidine per dose, 2 times daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 150 mg per dose, 2 times daily, or 300 mg once daily at bedtime. A higher healing rate may be achieved in patients with duodenal ulcers by administering 300 mg per dose, 2 times daily, in the morning and at bedtime. The dosage is the same for concomitant therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 150 mg per dose, 2 times daily for 8 weeks, or 300 mg once daily before bedtime. The dose may be increased to 150 mg per dose, 4 times daily, in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with 150 mg per dose, 3 times daily, and increase the dose if necessary. For severe disease, up to 6 g per day may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injection; once oral administration is possible, switch to oral administration and give 150 mg per dose, 2 times daily. 5) Premedication for anesthesia (prevention of Mendelson's syndrome) Administer 150 mg 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) associated with the following conditions: acute gastritis, acute exacerbation of chronic gastritis Administer 150 mg per dose, once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the blood concentration of the medicine, so adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
For patients aged 12 years and older, administer 75 mg per dose, 2 times daily (liquid formulation only). For patients aged 8 〜 18 years, up to 150 mg per dose (2 mg per kg of body weight), 2 times daily, may be administered.
This medication should not be used in patients with a known allergy to its components or a history of acute porphyria. In patients with impaired kidney function, this drug may remain in the body longer, requiring cautious use with reduced dosage or increased dosing intervals. Patients with poor liver function, a history of drug allergies, elderly patients, and those taking NSAIDs should also exercise caution. Particularly, as it may mask the symptoms of gastric cancer, patients with gastric ulcers or those over middle age who have recently experienced new dyspeptic symptoms should verify that they do not have a malignant condition before using this medication. Patients with gastric or duodenal ulcers that are Helicobacter pylori positive should undergo treatment to eradicate the bacteria simultaneously. This medication may rarely cause serious allergic reactions or blood dyscrasias, liver dysfunction, heart problems, gastrointestinal symptoms, neurological effects, and skin rashes, so if any unusual symptoms occur, the medication should be discontinued immediately and a doctor consulted. During treatment, regular blood tests and liver and kidney function tests should be conducted to closely monitor the patient’s condition. Elderly patients or those with chronic lung diseases, diabetes, or weakened immune systems have an increased risk of pneumonia and should be cautioned. After taking this medication, if experiencing dizziness or drowsiness, driving or operating hazardous machinery should be avoided. When taken with other medications, as this drug may affect the absorption or excretion of other drugs, consultation with a pharmacist or physician may be necessary to adjust the dosage. Women who are pregnant or may become pregnant, as well as nursing mothers, should carefully weigh the risks and benefits of using this medication. The safety of this drug in children has not been fully established, so caution is advised when using it in pediatric patients. In cases of overdose, actions such as vomiting or gastric lavage can be taken, and blood dialysis may be performed if necessary to remove the drug. Keep out of reach of children, and it is better not to transfer to another container.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light to enter. It should also be kept in a dry place to maintain the drug's effectiveness.
White round film-coated tablets
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Pharmaking Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.